INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
LR

Luly Jay R.

Director, President and CEOCIK 0001571211

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 1
Max Insider Score39
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
15.2K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ENANTA PHARMACEUTICALS INCDirector, President and CEO · Nov 26, 2025
5
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A
—
4,800 sh
Feb 12, 2026
Feb 13, 2026
traded Feb 12, 2026
+1d
SEC FORM 4

Evidence

8
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Tax withholding
F$88K
6,155 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

39
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Open-market sale
SELL$67K
4,743 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC FORM 4

Evidence

9
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Tax withholding
F$27K
1,885 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC FORM 4

Evidence

9
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
310.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC FORM 4

Evidence